PharmaMar ha hecho públicos los resultados finales de su ensayo clínico APLICOV-PC 1 con plitidepsina, registrado con el nombre de Aplidin, para el tratamiento de pacientes adultos con COVID-19, que requieren ingreso hospitalario, y que ha logrado alcanzar el objetivo primario de seguridad, mostrando eficacia clínica.
Researchers have been working tirelessly to find an effective treatment for people with COVID-19. Here's a look at the most promising medications being tested.
A cancer drug based on a compound found in a rare sea creature is 30 to 100 times more powerful against the virus that causes COVID-19 than remdesivir, according to a new set of experiments reported in Science.
The UCSF-led team racing to find a COVID cure may have found a promising candidate
FacebookTwitterEmail
1of5
Aplidium albicans is a marine invertebrate that lives off the shores of a tiny, uninhabited island in the Mediterranean Sea.Courtesy of Pharma MarShow MoreShow Less
2of5
Aplidium albicans a type of “sea squirt” found near
Es Vedrà off the coast of Ibiza. (Photo by Andres Iglesias/Getty Images)Andres Iglesias / Getty ImagesShow MoreShow Less
3of5
Aplidium albicans a type of “sea squirt” found near
Es Vedrà off the coast of Ibiza. (Photo by Michael Gottschalk/Photothek via Getty Images)Michael Gottschalk / Photothek via Getty ImagesShow MoreShow Less